Eli Lilly Must Pay Royalties In Diabetes Drug Row, Judge Says

By Andrew Karpan (October 20, 2021, 8:53 PM EDT) -- A federal judge has determined that Eli Lilly owes an Arizona company a portion of the billions of dollars in sales from its insulin brands, citing a 1992 royalty agreement that allowed the pharmaceutical giant to use a certain strain of yeast to help develop the drugs.

Eli Lilly owes an Arizona company a portion of the billions of dollars in sales from its insulin brands, a federal judge ruled Wednesday. (AP Photo/Darron Cummings) The ruling by U.S. District Judge Scott H. Rash came down late Tuesday in Arizona federal court, over two months after he heard dueling summary judgment motions from...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!